ReviewCureus2025

Microvascular Outcomes of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Type 2 Diabetes: A Systematic Review of Retinopathy and Nephropathy Evidence.

Atia Arif et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.